Breaking immune isolation in glioblastoma
Drug Resistance Updates · 2026
DOI: 10.1016/j.drup.2026.101412 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2026. Verfasst von Ji-Yong Sung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Republic of Korea…. Hauptthemen laut MEDLINE: Glioblastoma, Tumor Microenvironment, Brain Neoplasms, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 272 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul National University Bundang Hospital, Ministry of Health and Welfare, National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Republic of Korea. Electronic address: 5rangepineapple@gmail.com.
- Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Republic of Korea. Electronic address: coolghh@gmail.com.
Förderung
- Seoul National University Bundang Hospital
- Ministry of Health and Welfare
- National Research Foundation of Korea
- Korea Health Industry Development Institute
- Ministry of Science and ICT, South Korea
Zitieren
APA
Sung, J. Y., & Hwang, K. (2026). Breaking immune isolation in glioblastoma. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101412
Vancouver
Sung JY, Hwang K. Breaking immune isolation in glioblastoma. Drug Resistance Updates. 2026. doi:10.1016/j.drup.2026.101412
BibTeX
@article{Sung2026,
author = {Sung, Ji-Yong and Hwang, Kihwan},
title = {Breaking immune isolation in glioblastoma},
journal = {Drug Resistance Updates},
year = {2026},
doi = {10.1016/j.drup.2026.101412}
}
EUVIMED